The current price of NKTX is $1.57 — it has decreased by 9.25% since the previous close. Data as of Nov 5, 2026.
NKTX is down 5.42% over the past week, down 37.94% over the past month and down 19.49% over the past year. The price is below its 200-day moving average of $2.53.
Nkarta, Inc. has a market capitalization of $112.45M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
Nkarta, Inc. has not paid any dividends over the past year.
Companies most comparable to Nkarta, Inc. include Forte Biosciences, Inc., Vor Biopharma Inc., Cybin Inc., Alector, Inc. and Fate Therapeutics, Inc.
In the latest trading session NKTX moved between $1.57 and $1.72, a range of 9.87% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Nkarta, Inc. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks NKTX has traded between $1.48 and $3.72. The current price is 57.80% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.